
North America Biobanking Market Report and Forecast 2025-2034
Description
North America biobanking market size was valued at USD 1.10 Billion in 2024, driven by the rising prevalence of chronic diseases and the growing demand for effective treatments in the region. The market is expected to grow at a CAGR of 6.31% during the forecast period of 2025-2034, with the values likely to rise from USD 2.03 Billion by 2034.
North America Biobanking Market Analysis
Biobank is a type of biorepository containing large collections of biological materials (usually human). The large-scale biomedical database acts as a research resource to facilitate new scientific discoveries. Biological samples in biobanks can act as a vital tool for medical research and accelerate the development of new and innovative treatments.
North America biobanking market growth is driven by the rising prevalence of chronic diseases, such as cancer, cardiovascular diseases, and diabetes, in the region. According to the Centers for Disease Control and Prevention, 6 out of 10 Americans are affected by at least one chronic disease. Moreover, chronic diseases not only rank as the leading causes of death and disability in America but are also a major driver of healthcare costs. Biobanks help in studying the genetic and environmental factors resulting in chronic diseases. Thus, with the growing prevalence of chronic diseases, the demand for biological samples in biomedical research is expected to rise, which will boost the market growth.
Technological advancements such as the development of computational tools to analyze huge volumes of complex data in biobanks are expected to boost the North America biobanking market demand in the forecast period. In December 2023, a study primarily funded by the National Institute of Aging (a division of the United States National Institutes of Health) revealed the development of a suite of free computational tools that can analyze brain dissection photographs from brain biobanks and reconstruct a three-dimensional picture of the brain, which can help to understand neurodegenerative diseases and find their potential treatments. Thus, data from biobanks is increasingly used to advance the understanding of various brain disorders, which are anticipated to propel the market demand.
North America biobanking market share is likely to be positively impacted by increased fundings from government organizations to improve biobanking infrastructure and support research initiatives. In December 2023, New York-based Wilmot Cancer Institute (leader in cancer care and research) received a grant worth USD 339k from Empire State Development (New York State funds). The funding will help in renovations and the establishment of new technology for the institute’s Biobank Shared Resource. Such investments will support biobank upgrades and are likely to augment market size in the region.
North America Biobanking Market Segmentation
North America Biobanking Market Report and Forecast 2025-2034 offers a detailed analysis of the market based on the following segments:
Breakup by Equipment
The key features of the market report include patent analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players. The major companies in the market are as follows:
*Please Note:* The report will take 5 business days to complete, after order confirmation.
North America Biobanking Market Analysis
Biobank is a type of biorepository containing large collections of biological materials (usually human). The large-scale biomedical database acts as a research resource to facilitate new scientific discoveries. Biological samples in biobanks can act as a vital tool for medical research and accelerate the development of new and innovative treatments.
North America biobanking market growth is driven by the rising prevalence of chronic diseases, such as cancer, cardiovascular diseases, and diabetes, in the region. According to the Centers for Disease Control and Prevention, 6 out of 10 Americans are affected by at least one chronic disease. Moreover, chronic diseases not only rank as the leading causes of death and disability in America but are also a major driver of healthcare costs. Biobanks help in studying the genetic and environmental factors resulting in chronic diseases. Thus, with the growing prevalence of chronic diseases, the demand for biological samples in biomedical research is expected to rise, which will boost the market growth.
Technological advancements such as the development of computational tools to analyze huge volumes of complex data in biobanks are expected to boost the North America biobanking market demand in the forecast period. In December 2023, a study primarily funded by the National Institute of Aging (a division of the United States National Institutes of Health) revealed the development of a suite of free computational tools that can analyze brain dissection photographs from brain biobanks and reconstruct a three-dimensional picture of the brain, which can help to understand neurodegenerative diseases and find their potential treatments. Thus, data from biobanks is increasingly used to advance the understanding of various brain disorders, which are anticipated to propel the market demand.
North America biobanking market share is likely to be positively impacted by increased fundings from government organizations to improve biobanking infrastructure and support research initiatives. In December 2023, New York-based Wilmot Cancer Institute (leader in cancer care and research) received a grant worth USD 339k from Empire State Development (New York State funds). The funding will help in renovations and the establishment of new technology for the institute’s Biobank Shared Resource. Such investments will support biobank upgrades and are likely to augment market size in the region.
North America Biobanking Market Segmentation
North America Biobanking Market Report and Forecast 2025-2034 offers a detailed analysis of the market based on the following segments:
Breakup by Equipment
- Cryogenic Storage Systems
- Alarm Monitoring Systems
- Others
- Optimized Media
- Non-Optimized Media
- Others
- Human Tissue Biobanking
- Stem Cell Biobanking
- Cord Banking
- DNA/RNA Biobanking
- Others
- Human Tissues
- Human Organs
- Stem Cells
- Others
- Drug Discovery
- Disease Research
- Others
- Hospitals
- Cosmetology Clinics
- Ambulatory Surgical Centers
- Others
- United States of America
- Canada
The key features of the market report include patent analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players. The major companies in the market are as follows:
- Atlanta Biologicals Inc. (Bio-Techne Corporation)
- Becton, Dickinson and Company
- BioLifeSolution Inc.
- Chart Industries Inc.
- Hamilton Company
- Qiagen NV
- Sigma-Aldrich Inc. (Merck KGaA)
- STEMCELL Technologies Inc.
- Thermo Fisher Scientific Inc.
- VWR International LLC
*Please Note:* The report will take 5 business days to complete, after order confirmation.
Table of Contents
250 Pages
- 1 Preface
- 1.1 Objectives of the Study
- 1.2 Key Assumptions
- 1.3 Report Coverage – Key Segmentation and Scope
- 1.4 Research Methodology
- 2 Executive Summary
- 3 North America Biobanking Market Overview
- 3.1 North America Biobanking Market Historical Value (2018-2024)
- 3.2 North America Biobanking Market Forecast Value (2025-2034)
- 4 North America Biobanking Market Landscape*
- 4.1 North America Biobanking: Developers Landscape
- 4.1.1 Analysis by Year of Establishment
- 4.1.2 Analysis by Company Size
- 4.1.3 Analysis by Region
- 4.2 North America Biobanking: Product Landscape
- 4.2.1 Analysis by Equipment
- 4.2.2 Analysis by Service
- 5 North America Biobanking Market Dynamics
- 5.1 Market Drivers and Constraints
- 5.2 SWOT Analysis
- 5.2.1 Strengths
- 5.2.2 Weaknesses
- 5.2.3 Opportunities
- 5.2.4 Threats
- 5.3 Porter’s Five Forces Analysis
- 5.3.1 Bargaining Power of Suppliers
- 5.3.2 Bargaining Power of Buyers
- 5.3.3 Threat of New Entrants
- 5.3.4 Threat of Substitutes
- 5.3.5 Degree of Rivalry
- 5.4 Key Demand Indicators
- 5.5 Key Price Indicators
- 5.6 Industry Events, Initiatives, and Trends
- 5.7 Value Chain Analysis
- 6 North America Biobanking Market Segmentation (218-2034)
- 6.1 North America Biobanking Market (2018-2034) by Equipment
- 6.1.1 Market Overview
- 6.1.2 Cryogenic Storage Systems
- 6.1.3 Alarm Monitoring Systems
- 6.1.4 Others
- 6.2 North America Biobanking Market (2018-2034) by Media
- 6.2.1 Market Overview
- 6.2.2 Optimized Media
- 6.2.3 Non-Optimized Media
- 6.2.4 Others
- 6.3 North America Biobanking Market (2018-2034) by Services
- 6.3.1 Market Overview
- 6.3.2 Human Tissue Biobanking
- 6.3.3 Stem Cell Biobanking
- 6.3.4 Cord Banking
- 6.3.5 DNA/RNA Biobanking
- 6.3.6 Others
- 6.4 North America Biobanking Market (2018-2034) by Biospecimen Type
- 6.4.1 Market Overview
- 6.4.2 Human Tissues
- 6.4.3 Human Organs
- 6.4.4 Stem Cells
- 6.4.5 Others
- 6.5 North America Biobanking Market (2018-2034) by Application
- 6.5.1 Market Overview
- 6.5.2 Drug Discovery
- 6.5.3 Disease Research
- 6.5.4 Others
- 6.6 North America Biobanking Market (2018-2034) by End User
- 6.6.1 Market Overview
- 6.6.2 Hospitals
- 6.6.3 Cosmetology Clinics
- 6.6.4 Ambulatory Surgical Centers
- 6.6.5 Others
- 6.7 North America Biobanking Market (2018-2034) by Countries
- 6.7.1 Market Overview
- 6.7.2 United States of America
- 6.7.3 Canada
- 7 United States of America Biobanking Market (218-2034)
- 7.1 United State of America Biobanking Market (2018-2034) by Equipment
- 7.1.1 Market Overview
- 7.1.2 Cryogenic Storage Systems
- 7.1.3 Alarm Monitoring Systems
- 7.1.4 Others
- 7.2 United State of America Biobanking Market (2018-2034) by Media
- 7.2.1 Market Overview
- 7.2.2 Optimized Media
- 7.2.3 Non-Optimized Media
- 7.2.4 Others
- 7.3 United state of America Biobanking Market (2018-2034) by Services
- 7.3.1 Market Overview
- 7.3.2 Human Tissue Biobanking
- 7.3.3 Stem Cell Biobanking
- 7.3.4 Cord Banking
- 7.3.5 DNA/RNA Biobanking
- 7.3.6 Others
- 7.4 United State of America Biobanking Market (2018-2034) by Biospecimen Type
- 7.4.1 Market Overview
- 7.4.2 Human Tissues
- 7.4.3 Human Organs
- 7.4.4 Stem Cells
- 7.4.5 Others
- 7.5 United State of America Biobanking Market (2018-2034) by Application
- 7.5.1 Market Overview
- 7.5.2 Drug Discovery
- 7.5.3 Disease Research
- 7.5.4 Others
- 7.6 United State of America Biobanking Market (2018-2034) by End User
- 7.6.1 Market Overview
- 7.6.2 Hospitals
- 7.6.3 Cosmetology Clinics
- 7.6.4 Ambulatory Surgical Centers
- 7.6.5 Others
- 8 Canada Biobanking Market (218-2034)
- 8.1 Canada Biobanking Market (2018-2034) by Equipment
- 8.1.1 Market Overview
- 8.1.2 Cryogenic Storage Systems
- 8.1.3 Alarm Monitoring Systems
- 8.1.4 Others
- 8.2 Canada Biobanking Market (2018-2034) by Media
- 8.2.1 Market Overview
- 8.2.2 Optimized Media
- 8.2.3 Non-Optimized Media
- 8.2.4 Others
- 8.3 Canada Biobanking Market (2018-2034) by Services
- 8.3.1 Market Overview
- 8.3.2 Human Tissue Biobanking
- 8.3.3 Stem Cell Biobanking
- 8.3.4 Cord Banking
- 8.3.5 DNA/RNA Biobanking
- 8.3.6 Others
- 8.4 Canada Biobanking Market (2018-2034) by Biospecimen Type
- 8.4.1 Market Overview
- 8.4.2 Human Tissues
- 8.4.3 Human Organs
- 8.4.4 Stem Cells
- 8.4.5 Others
- 8.5 Canada Biobanking Market (2018-2034) by Application
- 8.5.1 Market Overview
- 8.5.2 Drug Discovery
- 8.5.3 Disease Research
- 8.5.4 Others
- 8.6 Canada Biobanking Market (2018-2034) by End User
- 8.6.1 Market Overview
- 8.6.2 Hospitals
- 8.6.3 Cosmetology Clinics
- 8.6.4 Ambulatory Surgical Centers
- 8.6.5 Others
- 9 Regulatory Framework
- 10 Patent Analysis
- 10.1 Analysis by Type of Patent
- 10.2 Analysis by Publication year
- 10.3 Analysis by Issuing Authority
- 10.4 Analysis by Patent Age
- 10.5 Analysis by CPC Analysis
- 10.6 Analysis by Patent Valuation
- 10.7 Analysis by Key Players
- 11 Funding and Investment Analysis
- 11.1 Analysis by Funding Instances
- 11.2 Analysis by Type of Funding
- 11.3 Analysis by Funding Amount
- 11.4 Analysis by Leading Players
- 11.5 Analysis by Leading Investors
- 11.6 Analysis by Geography
- 12 Partnership and Collaborations Analysis
- 12.1 Analysis by Partnership Instances
- 12.2 Analysis by Type of Partnership
- 12.3 Analysis by Leading Players
- 12.4 Analysis by Geography
- 13 Supplier Landscape
- 13.1 Market Share by Top 5 Companies
- 13.2 Atlanta Biologicals Inc. (Bio-Techne Corporation)
- 13.2.1 Financial Analysis
- 13.2.2 Product Portfolio
- 13.2.3 Demographic Reach and Achievements
- 13.2.4 Mergers and Acquisitions
- 13.2.5 Certifications
- 13.3 Becton, Dickinson and Company
- 13.3.1 Financial Analysis
- 13.3.2 Product Portfolio
- 13.3.3 Demographic Reach and Achievements
- 13.3.4 Mergers and Acquisitions
- 13.3.5 Certifications
- 13.4 BioLifeSolution Inc.
- 13.4.1 Financial Analysis
- 13.4.2 Product Portfolio
- 13.4.3 Demographic Reach and Achievements
- 13.4.4 Mergers and Acquisitions
- 13.4.5 Certifications
- 13.5 Chart Industries Inc.
- 13.5.1 Financial Analysis
- 13.5.2 Product Portfolio
- 13.5.3 Demographic Reach and Achievements
- 13.5.4 Mergers and Acquisitions
- 13.5.5 Certifications
- 13.6 Hamilton Company
- 13.6.1 Financial Analysis
- 13.6.2 Product Portfolio
- 13.6.3 Demographic Reach and Achievements
- 13.6.4 Mergers and Acquisitions
- 13.6.5 Certifications
- 13.7 Qiagen NV
- 13.7.1 Financial Analysis
- 13.7.2 Product Portfolio
- 13.7.3 Demographic Reach and Achievements
- 13.7.4 Mergers and Acquisitions
- 13.7.5 Certifications
- 13.8 Sigma-Aldrich Inc. (Merck KGaA)
- 13.8.1 Financial Analysis
- 13.8.2 Product Portfolio
- 13.8.3 Demographic Reach and Achievements
- 13.8.4 Mergers and Acquisitions
- 13.8.5 Certifications
- 13.9 STEMCELL Technologies Inc.
- 13.9.1 Financial Analysis
- 13.9.2 Product Portfolio
- 13.9.3 Demographic Reach and Achievements
- 13.9.4 Mergers and Acquisitions
- 13.9.5 Certifications
- 13.10 Thermo Fisher Scientific Inc.
- 13.10.1 Financial Analysis
- 13.10.2 Product Portfolio
- 13.10.3 Demographic Reach and Achievements
- 13.10.4 Mergers and Acquisitions
- 13.10.5 Certifications
- 13.11 VWR International LLC
- 13.11.1 Financial Analysis
- 13.11.2 Product Portfolio
- 13.11.3 Demographic Reach and Achievements
- 13.11.4 Mergers and Acquisitions
- 13.11.5 Certifications
- 14 North America Biobanking Market – Distribution Model (Additional Insight)
- 14.1 Overview
- 14.2 Potential Distributors
- 14.3 Key Parameters for Distribution Partner Assessment
- 15 Key Opinion Leaders (KOL) Insights (Additional Insight)
- 16 Company Competitiveness Analysis (Additional Insight)
- 16.1 Very Small Companies
- 16.2 Small Companies
- 16.3 Mid-Sized Companies
- 16.4 Large Companies
- 16.5 Very Large Companies
- 17 Payment Methods (Additional Insight)
- 17.1 Government Funded
- 17.2 Private Insurance
- 17.3 Out-of-Pocket
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.